Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 58,269 |
|
|||||
| News | - | ||||||
| Day High | 0.9448 | Low High |
|||||
| Day Low | 0.892 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Enveric Biosciences Inc | ENVB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 1.11% | 0.91 | 17:53:54 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.93 | 0.892 | 0.9448 | 0.895 | 0.90 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 251 | 58,269 | US$ 0.9058288 | US$ 52,782 | - | 0.649 - 6.98 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:15:15 | formt | 100 | US$ 0.91 | USD |
Enveric Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.09M | 2.32M | - | 0 | -17.46M | -7.52 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Enveric Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/26/2024 | 06:00 | Business Wire | Enveric Biosciences Reports Financial Results and Provides.. |
| 3/19/2024 | 06:00 | Business Wire | Enveric Biosciences Signs Non-Binding Term Sheets to Pursue.. |
| 3/12/2024 | 06:00 | Business Wire | Enveric Biosciences Announces New Patent Issuances.. |
| 3/11/2024 | 11:35 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 3/11/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 06:00 | Business Wire | Enveric Biosciences Signs Non-Binding Term Sheets to Pursue.. |
| 2/26/2024 | 15:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/26/2024 | 15:47 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/26/2024 | 15:42 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/23/2024 | 07:00 | Business Wire | Enveric Biosciences Agrees to Sell Cancer-Targeting.. |
| 2/21/2024 | 07:05 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ENVB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.92 | 0.98 | 0.8558 | 0.8987939 | 117,036 | -0.01 | -1.09% |
| 1 Month | 0.9243 | 1.19 | 0.83 | 1.01 | 248,405 | -0.0143 | -1.55% |
| 3 Months | 0.8605 | 2.92 | 0.7531 | 1.37 | 4,706,243 | 0.0495 | 5.75% |
| 6 Months | 1.88 | 2.92 | 0.649 | 1.36 | 2,221,607 | -0.97 | -51.60% |
| 1 Year | 1.63 | 6.98 | 0.649 | 2.55 | 2,010,837 | -0.72 | -44.17% |
| 3 Years | 2.35 | 14.87 | 0.1551 | 2.01 | 1,685,236 | -1.44 | -61.28% |
| 5 Years | 6.00 | 14.87 | 0.1551 | 2.61 | 2,067,447 | -5.09 | -84.83% |
Enveric Biosciences Description
| Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). |
